Clinical Trials - FMS

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07004907Efficacy and Tolerability of the APD Treatment in PAED PatientsNOT_YET_RECRUITINGNA2026-012026-112026-11
NCT06593392Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe PruritusRECRUITINGPHASE22025-12-292029-08-302029-08-30
NCT06390592Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe HarmonyNOT_YET_RECRUITINGNA2025-122026-122026-01
NCT06443021Influence of Variable Inflow Volume, Dwell Duration and Glucose Concentration on Ultrafiltration Volume in APD PatientsWITHDRAWNNA2025-102025-122025-10
NCT06341452Comparison of Individualized Sodium Management Versus Standard Treatment in HemodialysisNOT_YET_RECRUITINGNA2025-102026-122026-12
NCT06603324Analysis of Paediatric Treatments With multiFiltratePRONOT_YET_RECRUITINGNA2025-102026-122026-10
NCT05106491Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock PatientsNOT_YET_RECRUITINGNA2025-092026-092026-09
NCT06892249Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in TaiwanNOT_YET_RECRUITINGNA2025-05-012026-04-302025-11-15
NCT06902402Evaluation of Safety and Efficacy of Three Flavors of Supportan® Drink in Cancer Patients in TaiwanNOT_YET_RECRUITINGNA2025-04-142025-12-312025-09-30
NCT06049680Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsRECRUITINGPHASE42024-10-282026-092026-03
NCT06382675Clinical Performance of the New Plasma Filter PX2 in TPE TreatmentsRECRUITINGNA2024-07-182026-032025-12
NCT05339139SAfety of Regional Citrate Anticoagulation (SARCA Study)RECRUITINGPHASE32023-10-172025-07-312025-04-30
NCT05885763Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on HaemodialysisCOMPLETEDPHASE12023-06-262023-10-092023-10-09
NCT05885737Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe PruritusCOMPLETEDPHASE32023-05-182024-09-252024-09-25
NCT03584295Early Extubation by ECCO2R Compared to IMV in Patients with Severe Acute Exacerbation of COPDTERMINATEDNA2023-02-072024-11-252024-11-01
NCT05606848To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal CancerRECRUITINGNA2022-11-302025-032025-03
NCT05315817Safety and Performance Evaluation of multiPlus Dialysate During CRRTTERMINATEDNA2022-05-312023-01-242022-10-28
NCT04871893Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration TherapyCOMPLETEDNA2022-03-252024-12-312024-12-06
NCT05257031Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive CareCOMPLETEDPHASE32022-02-122023-06-302022-09-11
NCT05136664Trial Evaluating the Efficacy and Safety of Patiromer in Chinese SubjectsRECRUITINGPHASE32022-02-102025-11-302025-08-31
NCT05081648Must Cannulation Technique of Vascular Access in Patients Undergoing Haemodialysis: Contributions for a Safe Nursing InterventionCOMPLETEDNA2022-01-032023-04-302022-04-30
NCT04934072A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE32021-06-162023-08-072023-08-07
NCT04749680Comparison of Efficacy and Tolerability of APD Treatment With Different PD CyclersCOMPLETEDNA2021-05-312021-10-122021-10-12
NCT04714281Comparison of Clinical Performance and Hemocompatibility of Dialyzers Applied During Post-dilution Online HemodiafiltrationCOMPLETEDNA2021-02-032023-05-052023-05-05
NCT04511338Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™COMPLETEDNA2020-11-022021-06-162021-05-21
NCT04573595Fresenius Noninvasive Blood Pressure ValidationCOMPLETEDNA2020-09-172020-12-042020-12-04
NCT04512001MSB11456 in Participants With Moderately to Severely Active Rheumatoid ArthritisCOMPLETEDPHASE32020-08-032022-06-062021-08-31
NCT05333692Oral Nutritional Supplementation of Hemodialysis PatientsCOMPLETEDNA2020-07-012021-05-062021-05-06
NCT03563222Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of AgeTERMINATEDPHASE42019-12-182022-07-082020-11-12
NCT03992716Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical IllnessTERMINATEDPHASE42019-11-262020-03-242020-03-24
NCT04102280Comparative Clinical Performance of Dialyzers Applied During High Volume Online HaemodiafiltrationCOMPLETEDNA2019-10-292021-05-262020-11-06
NCT04078698Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical RoutineCOMPLETEDNA2019-09-052025-08-152025-05-30
NCT04018599Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSCOMPLETEDPHASE12019-07-152020-03-172020-03-17
NCT03338218Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma PatientsCOMPLETEDPHASE42019-02-232022-06-252022-06-25
NCT03792100Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral NutritionCOMPLETEDPHASE32019-01-032020-01-232020-01-23
NCT03795038Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALICOMPLETEDNA2018-12-282021-05-252021-05-25
NCT03214627Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) TrialTERMINATEDNA2018-12-102019-05-212019-05-21
NCT03666546Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2COMPLETEDPHASE42018-11-262019-03-082019-03-05
NCT03644264PA21 Safety and Efficacy in Adult Chinese SubjectsCOMPLETEDPHASE32018-08-312020-08-212020-08-21
NCT03536663Clinical Study to Assess the Performance of the Dialyzer With Endexo™COMPLETEDNA2018-08-292019-06-172019-04-17
NCT03611218Comparative Safety and Clinical Performance of Dialyzers Applied During Post-dilution Online HemodiafiltrationCOMPLETEDNA2018-08-292018-12-082018-12-08
NCT03481894Study to Assess Safety and Efficacy of Kabiven® in Pediatric Patients 2 to 16 Years of AgeWITHDRAWNPHASE42018-032021-032020-03
NCT03355079Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer TherapyTERMINATEDPHASE42018-02-282019-04-052019-04-05
NCT03280901HaemoDialysis Interventions to REduce Multi-Organ Dysfunction and Effect on Quality of Life Assessed by MRI ScanningCOMPLETEDNA2018-01-082020-08-202019-05-25
NCT03792087Efficacy and Safety of SmofKabiven Peripheral Versus Compounded EmulsionCOMPLETEDPHASE32017-12-212018-12-302018-12-30
NCT03282851Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456COMPLETEDPHASE12017-11-272019-10-012019-10-01
NCT03161158PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart FailureTERMINATEDNA2017-11-032019-08-262019-08-26
NCT03315624Safety and Clinical Performance of a Dialyzer With a Modified Polysulfone MembraneCOMPLETEDNA2017-10-062018-03-142017-12-09
NCT03278548Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal SurgeryCOMPLETEDPHASE42017-09-282022-07-062022-04-09
NCT03292029Pilot Medical Evaluation of the T50 TestCOMPLETEDNA2017-09-222020-03-042019-10-05
NCT03251248Pharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy SubjectsCOMPLETEDPHASE12017-08-222018-10-172018-05-08
NCT03251339Safety and Immunogenicity of MSB11455 in Healthy ParticipantsCOMPLETEDPHASE12017-08-212018-09-222018-02-05
NCT03077048Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) PatientsCOMPLETEDPHASE1, PHASE22017-03-302018-05-022018-04-27
NCT03052322MSB11022 in Moderate to Severe Rheumatoid ArthritisCOMPLETEDPHASE32017-01-312018-08-272018-05-28
NCT02968498Blood Glucose Response After Oral Intake of Lactulose in Healthy VolunteersCOMPLETEDNA2016-112017-022017-02
NCT02938234Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Free IntakeCOMPLETEDNA2016-092016-102016-10
NCT02938247Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled IntakeCOMPLETEDNA2016-092016-102016-10
NCT02795039Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female SubjectsCOMPLETEDPHASE12016-062017-03-032017-03-03
NCT02688764A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With HyperphosphataemiaTERMINATEDPHASE32016-05-262019-02-212019-02-21
NCT02660580MSB11022 in Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE32016-02-162017-12-182016-12-31
NCT02579265Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and InfantsTERMINATEDPHASE32015-122020-04-102020-04-03
NCT02503527Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin TherapyTERMINATEDNA2015-082018-092018-08
NCT02334267Acid-Base Composition With Use of hemoDialysatesCOMPLETEDNA2014-112015-092015-02
NCT03014947MSB11022 in Healthy SubjectsCOMPLETEDPHASE12014-052014-122014-12
NCT02027662Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® GranulesCOMPLETEDPHASE2, PHASE32014-012015-062015-04
NCT02096237Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study)COMPLETEDNA2013-122014-112014-07
NCT02086227Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)COMPLETEDPHASE12013-052013-062013-06
NCT01856998Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective SurgeryCOMPLETEDPHASE32013-052014-02
NCT01689506Fluid Resuscitation in Patients Suffering From Burns InjuryTERMINATEDPHASE42012-122013-092013-09
NCT01553617VolulyteTM in Cardiac SurgeryCOMPLETEDPHASE42012-102014-012014-01
NCT01997385The Clinical Effects of Korean Adapted APD in Automated Peritoneal Dialysis PatientsCOMPLETEDPHASE42012-062014-062014-04
NCT01532297Application of Citrate Dialysate in Chronic HaemodialysisCOMPLETEDNA2011-102013-082013-04
NCT01427907Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis PatientsCOMPLETEDPHASE42011-092012-072012-07
NCT01753154The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal DialysisCOMPLETEDPHASE42011-072013-122013-03
NCT01241695Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic PatientsCOMPLETEDNA2010-112011-122011-12
NCT01252771Phosphate Kinetic Modeling 2COMPLETEDPHASE42010-092011-122011-09
NCT01102218A Safety Study of Pentoxifylline for the Treatment of AnemiaTERMINATEDPHASE22010-082012-012012-01
NCT01127477Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective SurgeryCOMPLETEDPHASE32010-052010-122010-12
NCT01010022Trial of 6% HES130/0.4COMPLETEDPHASE32009-112010-112010-07
NCT01017627Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)UNKNOWNNA2009-112010-122010-11
NCT00851448Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer PatientsTERMINATEDNA2009-102011-042011-04
NCT01003223Phosphate Kinetic ModelingCOMPLETEDNA2009-102011-042010-10
NCT00852020Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease PatientsCOMPLETEDNA2009-042011-042011-04
NCT00860405Voluven® in Paediatric PatientsCOMPLETEDPHASE42009-032010-122010-08
NCT00915369A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast CancerUNKNOWNPHASE12009-032010-042010-04
NCT00730808Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before SurgeryCOMPLETEDNA2008-122009-112009-11
NCT00794326Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PDCOMPLETEDPHASE32008-102014-122014-12
NCT00742820Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy VolunteersCOMPLETEDPHASE12008-082008-112008-11
NCT01067313Continuous Hemodialysis With an Enhanced Middle Molecule Clearance MembraneCOMPLETEDPHASE2, PHASE32008-072011-012010-07
NCT00694343Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean SectionCOMPLETEDPHASE42008-062010-062009-12
NCT00662376Study on Safety, Tolerance and Metabolic Effects of a Nutritional Supplement, Given as a Drink Before Gallbladder SurgeryCOMPLETEDNA2008-042008-102008-10
NCT00600678Gastric Emptying Study After Administration of a High Caloric Sip FeedCOMPLETEDNA2007-112008-012007-12
NCT00451646Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral NutritionCOMPLETEDPHASE32007-102008-112008-10
NCT00464204Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe SepsisCOMPLETEDPHASE32007-072010-122010-05
NCT00503334Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral SurgeryCOMPLETEDNA2007-072008-052008-05
NCT00435123ProStat Supplementation in Dialysis PatientsTERMINATEDNA2007-072008-012008-01
NCT01025167The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer PatientsCOMPLETEDNA2006-092010-012010-01
NCT00363987Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)COMPLETEDPHASE42006-052009-062008-12
NCT00294866Effect of Paricalcitol on Markers of Inflammation in Hemodialysis PatientsCOMPLETEDPHASE42006-032008-012008-01
NCT00308100Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver TransplantationTERMINATEDPHASE42005-102008-072008-07
NCT00308126Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal SurgeryCOMPLETEDPHASE42005-062006-09
NCT00247338The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative PatientsCOMPLETEDPHASE42005-042006-052006-04
NCT00501956Intradialytic Parenteral Nutrition in Hemodialysis PatientsCOMPLETEDPHASE42004-072010-122010-12
NCT00292279The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer PatientsCOMPLETEDPHASE32002-062004-022003-11